Compare ORMP & CEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | CEPS |
|---|---|---|
| Founded | 2002 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 148.8M |
| IPO Year | 2010 | N/A |
| Metric | ORMP | CEPS |
|---|---|---|
| Price | $4.29 | $10.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 500.7K | 21.1K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.73 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $10.05 |
| 52 Week High | $5.19 | $10.45 |
| Indicator | ORMP | CEPS |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 63.59 |
| Support Level | $3.69 | $10.05 |
| Resistance Level | $5.10 | N/A |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 37.19 | 97.50 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Cantor Equity Partners VI Inc is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.